Heart transplantation (txp) exemplifies a high-technology biomedical intervention that is extremely costly in terms of economic and health care resources, yet provides highly-valued outcomes: it yields a dramatic extension of duration of life, and marked improvement in quality of life. Like many other major life-extending interventions, however, heart txp brings its own consequent stressors and morbidities. Most critically, it gives patients only a limited extension in life expectancy, usually far less than that based on chronological age. As the population of heart recipients grows, an expanding number of individuals will enter the late years of txp survivorship and face the inevitable physical deterioration that comes during these years. The psychological consequences of late term survivorship are unknown. In this application, we provide the economic, conceptual, and public health rationales for the need to consider these consequences at this time and in this population. There are no data on the nature or course of psychiatric morbidity that may accompany physical health declines, despite the potential impact of such psychiatric morbidity on txp recipients' quality of life and survival time. There are no data on whether the mental health of the patient's primary family caregiver is affected by late-term txp-related health changes. These data, plus identification of factors that create vulnerability or increase psychological resilience in the face of growing physical challenges for the patient will provide the critical knowledge base for the design of mental health interventions for both patients and caregivers during these years. We previously enrolled and followed the only cohort of heart recipients (n=250) ever to have received repeated, extensive psychiatric, behavioral, and psychosocial assessments across the early to middle (0-4) years posttxp. Their family caregiver's mental health and psycho-social status was also assessed. We plan to reassess all cohort survivors (n=132) and their caregivers. At study inception, the bulk of patients will be 9-13 years post-txp. We will collect 3 new waves of data separated by 1 year each in order to address a series of clinical epidemiologic questions pertaining to: (a) the prevalence of depressive and anxiety-related disorders during the late years post-txp, (b) the degree to which patients' and caregivers' risk for psychiatric morbidity in the face of late post-txp physical health stressors is moderated by key psychosocial characteristics, and (c) whether both parties' mental health, in turn, influences patients' continued medical compliance and subsequent physical morbidity. Data collection will involve semi-structured interviews, Txp Program staff evaluations, and medical record reviews.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
1R01MH072718-01A1
Application #
6969803
Study Section
Special Emphasis Panel (ZRG1-RPHB-J (04))
Program Officer
Muehrer, Peter R
Project Start
2005-07-15
Project End
2009-06-30
Budget Start
2005-07-15
Budget End
2006-06-30
Support Year
1
Fiscal Year
2005
Total Cost
$199,920
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Fox, Kristen R; Posluszny, Donna M; DiMartini, Andrea F et al. (2014) Predictors of post-traumatic psychological growth in the late years after lung transplantation. Clin Transplant 28:384-93
Shyu, Susan; Dew, Mary Amanda; Pilewski, Joseph M et al. (2011) Five-year outcomes with alemtuzumab induction after lung transplantation. J Heart Lung Transplant 30:743-54
Genovese, Elizabeth A; Dew, Mary Amanda; Teuteberg, Jeffrey J et al. (2010) Early adverse events as predictors of 1-year mortality during mechanical circulatory support. J Heart Lung Transplant 29:981-8
Dew, Mary Amanda; Dabbs, Annette DeVito; Myaskovsky, Larissa et al. (2009) Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation 88:736-46
Genovese, Elizabeth A; Dew, Mary Amanda; Teuteberg, Jeffrey J et al. (2009) Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 88:1162-70
Dew, Mary Amanda; DiMartini, Andrea F; Steel, Jennifer et al. (2008) Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs. Liver Transpl 14:159-72
DiMartini, Andrea; Crone, Catherine; Fireman, Marian et al. (2008) Psychiatric aspects of organ transplantation in critical care. Crit Care Clin 24:949-81, x
Dew, Mary Amanda; Dimartini, Andrea F; De Vito Dabbs, Annette et al. (2008) Adherence to the medical regimen during the first two years after lung transplantation. Transplantation 85:193-202
Dew, Mary Amanda; DiMartini, Andrea F; De Vito Dabbs, Annette et al. (2007) Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 83:858-73